HMGB1 and neoplasm: As presented in Figure 7E, we found that CD276 and VEGFA expression was significantly positively correlated with the expression of OTUD6B in nearly all types of cancer, so were the immune checkpoint inhibitor genes HMGB1 and TLR4, suggesting that OTUD6B may provide some help for tumor immunotherapy through these targets.